DD151307A5 - Verfahren zur herstellung von alphacarbamoyl-pyrrol-propionitrilen - Google Patents

Verfahren zur herstellung von alphacarbamoyl-pyrrol-propionitrilen Download PDF

Info

Publication number
DD151307A5
DD151307A5 DD80221679A DD22167980A DD151307A5 DD 151307 A5 DD151307 A5 DD 151307A5 DD 80221679 A DD80221679 A DD 80221679A DD 22167980 A DD22167980 A DD 22167980A DD 151307 A5 DD151307 A5 DD 151307A5
Authority
DD
German Democratic Republic
Prior art keywords
lower alkyl
enol
compounds
substituted
salts
Prior art date
Application number
DD80221679A
Other languages
German (de)
English (en)
Inventor
Gordon N Walker
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of DD151307A5 publication Critical patent/DD151307A5/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/32Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D207/33Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D207/337Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/34Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/34Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/36Oxygen or sulfur atoms
    • C07D207/402,5-Pyrrolidine-diones
    • C07D207/4162,5-Pyrrolidine-diones with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to other ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D261/00Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/02Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
    • C07D261/06Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
    • C07D261/10Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D261/18Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Rheumatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pain & Pain Management (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DD80221679A 1979-06-11 1980-06-09 Verfahren zur herstellung von alphacarbamoyl-pyrrol-propionitrilen DD151307A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US4606379A 1979-06-11 1979-06-11

Publications (1)

Publication Number Publication Date
DD151307A5 true DD151307A5 (de) 1981-10-14

Family

ID=21941390

Family Applications (1)

Application Number Title Priority Date Filing Date
DD80221679A DD151307A5 (de) 1979-06-11 1980-06-09 Verfahren zur herstellung von alphacarbamoyl-pyrrol-propionitrilen

Country Status (22)

Country Link
EP (2) EP0021207B1 (pt)
JP (1) JPS562961A (pt)
KR (4) KR840001131B1 (pt)
AT (1) ATE14724T1 (pt)
AU (1) AU539967B2 (pt)
CA (1) CA1133917A (pt)
CY (1) CY1426A (pt)
DD (1) DD151307A5 (pt)
DE (1) DE3070951D1 (pt)
DK (1) DK155996C (pt)
ES (1) ES8104223A1 (pt)
FI (1) FI71129C (pt)
GR (1) GR69239B (pt)
HK (1) HK50288A (pt)
HU (1) HU182670B (pt)
IE (1) IE50288B1 (pt)
IL (1) IL60269A (pt)
KE (1) KE3795A (pt)
NO (1) NO155197C (pt)
NZ (1) NZ193995A (pt)
PT (1) PT71367A (pt)
ZA (1) ZA803461B (pt)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2127809B (en) * 1982-09-28 1986-03-12 Ciba Geigy Ag Certain b-oxo-a-carbamoyl-pyrrolepropionitriles
DE3247454A1 (de) * 1982-12-22 1984-06-28 Laboratorios Bago S.A., Buenos Aires Substituierte 3-phenyl-5-methyl-isoxazol-4-carboxy-anilide, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
DE3525623A1 (de) * 1985-07-18 1987-01-22 Celamerck Gmbh & Co Kg Fungizid wirksame acrylsaeureamide
GB8619432D0 (en) * 1986-08-08 1986-09-17 Lilly Industries Ltd Pharmaceutical compounds
GB8619433D0 (en) * 1986-08-08 1986-09-17 Lilly Industries Ltd Pharmaceutical compounds
JPH02502534A (ja) * 1987-12-18 1990-08-16 チバ‐ガイギー アクチェンゲゼルシャフト 1‐メチル‐β‐オキソ‐α‐(フェニルカルバモイル)‐2‐ピロールプロピオニトリルのトロメタミン塩
IL92508A0 (en) * 1988-12-08 1990-08-31 Ciba Geigy Ag Novel alpha-cyano-beta-oxopropionamides
GR880100839A (el) * 1988-12-15 1994-03-31 Ciba Geigy Αλας τρομε?αμίνης του 1-με?ύλ-Β-ΟΞΟ-Α-(φαινυλοκαρβομουλό)-2-πυρρολοπροπιονιτριλίου.
AU625688B2 (en) * 1989-01-31 1992-07-16 Merrell Dow Pharmaceuticals Inc. Method of using aryl- or heteroaryl-1-alkyl-pyrrole-2- carboxylic acid compounds in the treatment of interleukin-1 mediated conditions
GB9720899D0 (en) * 1997-10-01 1997-12-03 Pharmacia & Upjohn Spa Condensed heterocyclic compounds
JP2005520835A (ja) * 2002-03-19 2005-07-14 バイエル ケミカルズ アクチエンゲゼルシャフト 光データキャリアの情報層における吸光性化合物としてのスクアリリウム色素

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE861500C (de) * 1942-07-05 1953-01-05 Beth Ag Maschf Spuelluftfilter
GB1201061A (en) * 1966-08-26 1970-08-05 Endo Lab Oxo pyrroles and process for preparing same
NL186239B (nl) * 1975-06-05 Hoechst Ag Werkwijze voor de bereiding van een geneesmiddel met antiflogistische en/of analgetische werking, alsmede werkwijze voor de bereiding van een 2-hydroxyethylideencyaanazijnzuuranilide geschikt voor toepassing bij deze werkwijze.
NL178596C (nl) * 1975-06-05 1986-04-16 Hoechst Ag Werkwijze voor het bereiden van een geneesmiddel met antiflogistische en/of analgetische werking, alsmede werkwijze voor het bereiden van daarin als geneeskrachtige verbindingen te gebruiken 5-methylisoxazool-4-carbonzuuraniliden.
DE2654797A1 (de) * 1976-12-03 1978-06-08 Hoechst Ag Verfahren zur herstellung von isoxazolderivaten

Also Published As

Publication number Publication date
ES492278A0 (es) 1981-04-01
HK50288A (en) 1988-07-15
IL60269A (en) 1983-12-30
ES8104223A1 (es) 1981-04-01
ATE14724T1 (de) 1985-08-15
KR840001133B1 (ko) 1984-08-09
DK155996B (da) 1989-06-12
KE3795A (en) 1988-03-11
EP0021207B1 (de) 1985-08-07
AU5917380A (en) 1980-12-18
GR69239B (pt) 1982-05-11
FI801840A (fi) 1980-12-12
NO801733L (no) 1980-12-12
NZ193995A (en) 1983-03-15
JPH0351704B2 (pt) 1991-08-07
PT71367A (en) 1980-07-01
KR840004678A (ko) 1984-10-22
DE3070951D1 (en) 1985-09-12
NO155197C (no) 1987-02-25
JPS562961A (en) 1981-01-13
DK250180A (da) 1980-12-12
EP0021207A1 (de) 1981-01-07
KR840001134B1 (ko) 1984-08-09
FI71129C (fi) 1986-11-24
HU182670B (en) 1984-02-28
EP0143142A2 (de) 1985-06-05
KR840001131B1 (ko) 1984-08-09
DK155996C (da) 1989-11-06
AU539967B2 (en) 1984-10-25
CY1426A (en) 1988-09-02
KR830002708A (ko) 1983-05-30
IL60269A0 (en) 1980-09-16
IE50288B1 (en) 1986-03-19
EP0143142A3 (de) 1985-07-17
CA1133917A (en) 1982-10-19
ZA803461B (en) 1981-06-24
KR840004677A (ko) 1984-10-22
NO155197B (no) 1986-11-17
IE801185L (en) 1980-12-11
KR840001132B1 (ko) 1984-08-09
FI71129B (fi) 1986-08-14

Similar Documents

Publication Publication Date Title
EP0004279B1 (de) Verfahren zur Herstellung von 4-Pyridon-3-carbonsäuren, 1-Cyclopropyl-4-Pyridon-3-Carbonsäurederivate und diese enthaltende Arzneimittel
DE3324034C2 (pt)
DE69200378T2 (de) Indolderivate, Verfahren zu deren Herstellung und diese enthaltende Arzneimittel.
DE1595915A1 (de) Verfahren zur Herstellung von heterocyclischen Benzamiden
AT262274B (de) Verfahren zur Herstellung neuer Indolderivate
EP0022078B1 (de) Pyrazolochinoline, Verfahren zu ihrer Herstellung, und pharmazeutische Präparate enthaltend diese Verbindungen
DE2537070C2 (pt)
EP0021207B1 (de) Alphacarbamoyl-pyrrolpropionitrile, Verfahren zu ihrer Herstellung, sowie pharmazeutische Präparate die diese Verbindungen enthalten
DE2234651C3 (de) Eckige Klammer auf l-(p-Chlorbenzoyl)-5-methoxy-2-methyl-3-indol] -acetoxj essigsaure, ihre Salze mit Basen, Verfahren zu ihrer Herstellung sowie pharmakologische Zubereitungen
EP0380712B1 (de) Verfahren zur Herstellung von 2,6-Dichlordiphenylaminessigsäurederivaten
EP0103142A1 (de) Thieno(2,3-e)-1,2-thiazin-Derivate
DE2600513A1 (de) Acylamino(alkyl)benzolderivate und verfahren zu ihrer herstellung
CH641162A5 (de) Verfahren zur herstellung neuer phenylazacycloalkane.
EP0012435A2 (de) Isoxazolderivate, Verfahren zu ihrer Herstellung, diese Verbindungen enthaltende Arzneimittel und bei dem Verfahren benötigte Zwischenprodukte
EP0301245B1 (de) 3-Sulfonyl-3,7-diazabicyclo-(3,3,1)nonan-Verbindungen sowie Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
CH450420A (de) Verfahren zur Herstellung von a-(3-Indolyl)-niederaliphatischen Säuren
EP0156091A1 (de) Beta-Oxo-alpha-carbamoyl-pyrrolpropionitrile, Verfahren zu ihrer Herstellung, pharmazeutische Präparate enthaltend diese Verbindungen, sowie ihre therapeutische Verwendung
DE2319280A1 (de) 1-substituierte pyrazolone-(5), verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
AT365200B (de) Verfahren zur herstellung von neuen thienothiazin-derivaten und von deren salzen
AT330744B (de) Verfahren zur herstellung von neuen 4- aminophenoxy- oder 4- aminophenylthio- 3- amino-5-sulfamoyl-benzoesauren sowie deren niederalkylestern und salzen
EP0090353A1 (de) Pyridon-2-derivate, Verfahren zu ihrer Herstellung und sie enthaltende Arzneimittel
DE2500692C3 (de) Derivate des 4-Amidoalkylen-4'oxy diphenyle
AT304485B (de) Verfahren zur Herstellung von neuen 1,2,3,4-Tetrahydronaphthalin-1-carbonsäuren, ihren Estern und Amiden
AT256095B (de) Verfahren zur Herstellung von neuen substituierten α-(3-Indolyl)-säureamiden
AT255418B (de) Verfahren zur Herstellung von neuen Sulfonamiden und ihren Salzen

Legal Events

Date Code Title Description
ENJ Ceased due to non-payment of renewal fee